Amanda M. Morgan serves as the Chief Commercial Officer at Lantheus Holdings Inc., a position she has held since joining the company in 2020. With a robust background in pharmaceuticals and medical technology, Amanda has been instrumental in steering Lantheus' commercial strategy, particularly in the areas of radiopharmaceuticals and diagnostic imaging agents. Her leadership has been pivotal in driving the company's growth and enhancing its market position within the healthcare industry. Prior to her role at Lantheus, Amanda held various senior positions at major healthcare companies. She spent over a decade at Novartis, where she progressed through roles in sales, marketing, and business development, culminating in her appointment as Vice President of Oncology for the U.S. market. During her tenure at Novartis, Amanda was recognized for her strategic vision and ability to drive product launches and revenue growth. Before Novartis, she worked at Johnson & Johnson, where she honed her skills in commercial operations and product management. Amanda's extensive experience and proven track record make her a valuable asset to Lantheus as they continue to innovate and expand their portfolio of life-saving medical technologies.